Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Recruiting

Phase 2

Psilocybin TherapyGroup Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Sponsor:

University of Washington

Code:

NCT07336238

Conditions

Anxiety

Depression

Hematopoietic and Lymphatic System Neoplasm

Metastatic Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Psychotherapy

Psilocybin

Survey Administration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-12. This information was provided to ClinicalTrials.gov by University of Washington on 2026-04-17.